• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者经动脉化疗栓塞后发热对萘普生反应的研究

Study of response to naproxen in patients with hepatocellular carcinoma who developed fever following transcatheter arterial embolization.

作者信息

Akaji H, Hagino M, Inoue K, Hirota N, Nakamura H

机构信息

Department of Internal Medicine, Nishiyodo Hospital, Japan.

出版信息

Radiat Med. 1990 Nov-Dec;8(6):227-9.

PMID:1965557
Abstract

Good antipyretic response was obtained when naproxen was given at 600 mg/day for about one week to patients who developed fever after transcatheter arterial embolization (TAE). Fever recurred in several patients, but subsided again when naproxen was given at 300 mg/day. No patients developed gastric mucosal lesions of clinical concern that seemed to be related to naproxen.

摘要

对于经导管动脉栓塞术(TAE)后出现发热的患者,给予萘普生600毫克/天,持续约一周,可获得良好的退热效果。部分患者发热复发,但给予萘普生300毫克/天治疗后,发热再次消退。没有患者出现似乎与萘普生相关的具有临床意义的胃黏膜病变。

相似文献

1
Study of response to naproxen in patients with hepatocellular carcinoma who developed fever following transcatheter arterial embolization.肝细胞癌患者经动脉化疗栓塞后发热对萘普生反应的研究
Radiat Med. 1990 Nov-Dec;8(6):227-9.
2
[The effect of naproxen on fever following transcatheter arterial embolization of hepatic tumors].[萘普生对肝肿瘤经导管动脉栓塞术后发热的影响]
Gan No Rinsho. 1988 Oct;34(12):1659-62.
3
Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.经导管部分脾动脉栓塞术治疗脾功能亢进患者:作为肝细胞癌和肝硬化辅助治疗的临床评估
Hepatogastroenterology. 1986 Jun;33(3):105-8.
4
Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.血清白细胞介素6作为经导管动脉栓塞术后治疗效果及不良反应的预测指标。
Cytokine. 1995 Feb;7(2):191-5. doi: 10.1006/cyto.1995.1026.
5
Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.经导管动脉栓塞术后肝细胞癌破裂:1例罕见病例
Hepatogastroenterology. 1999 Jan-Feb;46(25):453-6.
6
[Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].经导管动脉灌注化疗及经导管动脉栓塞术治疗132例原发性肝癌的疗效
Zhonghua Zhong Liu Za Zhi. 1999 May;21(3):211-3.
7
Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.经导管动脉栓塞术(TAE)治疗肝细胞癌后发生的急性胰腺炎。
Am J Gastroenterol. 1989 Nov;84(11):1396-9.
8
The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage.经导管动脉栓塞术在不可切除肝细胞癌患者中的作用:一项按癌症分期评估的全国性多中心研究
Aliment Pharmacol Ther. 2005 Mar 15;21(6):687-94. doi: 10.1111/j.1365-2036.2005.02404.x.
9
[Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].[部分脾栓塞术(PSE)在经导管动脉栓塞术(TAE)后有胃肠道出血风险的肝细胞癌中的应用价值]
Gan No Rinsho. 1989 May;35(6):690-5.
10
Rupture of hepatocellular carcinoma following transcatheter arterial embolization.经导管动脉栓塞术后肝细胞癌破裂
Radiat Med. 1988 Jul-Aug;6(4):147-9.